biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Some Reality Therapy

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on Nov 17, 2023 8:41am

111 Views

Post# 35740756

RE:Some Reality Therapy

InitiumMMXXIII wrote: With this post I am introducing my new Stockhouse alias, "InitiumMMXXIII". (Latin for "start 2023". It had to be something.) My previous alias was "Boomskid." At my request, SH retired that alias on Monday afternoon, November 13, 2023.

I wasn't going to get a new alias until some future date but this mornng there was news in our family that relates to the BBB and the treatment of brain tumours.

Three weeks ago or so, my wife's grandniece (granddaughter of her sister), suddenly became ill. Symptoms were confusing but within a day she was diagnosed with a brain tumour. She is 16 years old and had never had any health issues until this event.

She was operated on within 4 or 5 days of the first diagnosis. Word finally came through today that the tumour was glioblastoma, untreatable, and that she has days, perhaps weeks of time left to her.

Bioasis was created over 15 years ago to do something about this type of thing. One of the reasons I remained so passionate about the possibilities of xB3 was the possibility that it could effectively enable the treatment of a host of brain disorders of this sort.

For many years I wanted so badly to scream at Bioasis to get on with it, to do something. In the end, only Mark Day made an attempt at real preclinical work in support of future human clinical trials.

I'm not going to rehash it all here and now, but as this young girl's life ebbs away, and I watch the pain my wife and her family will be enduring for a long time, I will be thinking of Bioasis, and what could have been, and should have been, if xB3 works as we have been hoping for so, so, long.

jd